San Antonio Vaccine Development Center’s 1st symposium is Friday
The inaugural San Antonio Vaccine Symposium — “Vaccine Antigen Discovery and Vaccine-Induced Immunity” — presented by the San Antonio Vaccine Development (SAVE) Center
8 a.m. to 5:30 p.m. (Friday, Nov. 16)
The University of Texas Health Science Center San Antonio — Greehey Children’s Cancer Research Institute, 8403 Floyd Curl Drive (78229)
Dozens of local scientists will present their work. In addition, two nationally recognized vaccine researchers are the invited keynote speakers:
At 9 a.m. Roy Curtiss III, Ph.D., of Arizona State University, will discuss the use of Salmonella bacteria to treat infectious diseases and cancer. Salmonella infection is the most frequently reported cause of foodborne illness, but attenuated strains (modified to be less severe) are being studied as therapies.
At 2 p.m. Rafi Ahmed, Ph.D., of Emory University, will discuss how responses to an antigen (such as bacteria or fungi) are maintained or remembered by the immune system.
SAVE members are the UT Health Science Center, The University of Texas at San Antonio (UTSA), the Texas Biomedical Research Institute and the Southwest Research Institute. SAVE scientific co-directors are Bernard Arulanandam, Ph.D., of UTSA; Guangming Zhong, M.D., Ph.D., of the School of Medicine at the UT Health Science Center; Jean Patterson, Ph.D., of the Texas Biomedical Research Institute; and Michael MacNaughton, Ph.D., of Southwest Research Institute.